[Chlorambucil pulse therapy in progressive chronic polyarthritis. Initial results of an open multicenter study]. 1987

A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
Rheumatologische Universitätsklinik Basel, Schweiz.

The first preliminary clinical results with chlorambucil pulse-therapy in patients with refractory rheumatoid arthritis are reported, with a dose of chlorambucil below that which might risk inducing leukaemia. The clinical response was good in 15 out of 19 patients; symptoms and objective findings of rheumatoid arthritis had significantly improved. However, multiple toxic reactions have been identified in our patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002699 Chlorambucil A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed) 4-(Bis(2-chloroethyl)amino)benzenebutanoic Acid,Amboclorin,CB-1348,Chloraminophene,Chlorbutin,Leukeran,Lympholysin,N,N-Di-(2-chloroethyl)-p-aminophenylbutyric Acid,NSC-3088,CB 1348,CB1348,NSC 3088,NSC3088
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
January 1968, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
January 1984, Wiener klinische Wochenschrift. Supplementum,
A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
April 1970, Deutsche medizinische Wochenschrift (1946),
A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
January 1948, Revista espanola de reumatismo y enfermedades osteoarticulares,
A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
April 1967, Therapeutische Umschau. Revue therapeutique,
A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
October 1968, Die Medizinische Welt,
A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
April 1967, Therapeutische Umschau. Revue therapeutique,
A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
October 1970, Therapie der Gegenwart,
A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
January 1972, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
A Aeschlimann, and D Brackertz, and H Kaiser, and W Müller
August 1972, Therapeutische Umschau. Revue therapeutique,
Copied contents to your clipboard!